Definition
Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed)
Top Gene Interactions
Enoxaparin Interacts with Diseases
Disease | Inference Score | References/Inference Genes |
Factor X Deficiency | 6.44 |
|
Pasteurellaceae Infections | 5.55 |
|
Thrombosis | 5.54 |
|
Myocardial Ischemia | 4.89 |
|
Hyperparathyroidism, Secondary | 4.63 |
|
Periodontitis | 4.63 |
|
Blood Coagulation Disorders | 4.46 |
|
Leishmaniasis | 4.39 |
|
Metabolic Diseases | 4.39 |
|
Diabetic retinopathy | 4.34 |
|
Visceral leishmaniasis | 4.26 |
|
Meningitis | 4.21 |
|
Infection | 4.06 |
|
Malaria | 4.05 |
|
Mesothelioma | 4.03 |
|
Crohn's disease | 4.0 |
|
Diabetes Mellitus, Type 1 | 3.98 |
|
Acute coronary syndrome | 3.97 |
|
Metabolic Syndrome X | 3.95 |
|
Arsenic Poisoning | 3.89 |
|